Stephanie Maestre, MD
Foot and Ankle Surgery · Irwin, PANPI 1427408699
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (41.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. Arthrex accounts for 68.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $12,219 and has fallen 83.6% since, to $2,008 in 2025. Among foot and ankle surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 108 payments — averaging $240.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$18K
- Stryker$4K
- Mid-atlantic Surgical Systems, LLC$4K
- Zimmer Biomet$187
- Medical Device Business Services, Inc.$180
- Madrigal Pharmaceuticals$58
- plus $36 from 2 others
What the payments were for
- Grants$10,80542%
- Travel & lodging$7,65229%
- Food & beverage$2,52610%
- Education$4,98019%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 49 | $17,776 |
| Stryker(2 entities) | 39 | $4,192 |
| Mid-atlantic Surgical Systems, LLC | 12 | $3,532 |
| Zimmer Biomet | 3 | $187 |
| Medical Device Business Services, Inc. | 1 | $180 |
| Madrigal Pharmaceuticals | 2 | $58 |
| Zimvie Inc. | 1 | $24 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$1,373
- PROPHECY$1,081
- INBONE$871
- INVISION$871
- AUGMENT INJECTABLE$573
- INFINITY$465
- SALVATION$465
- ORTHOLOC 2 LAPIFUSE$465
- PRIME SERIES$168
- BLUEPRINT PSI SYSTEM$102
How this compares
$25,962 in reported general payments places this provider in the 90th percentile of 575 foot and ankle surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 28 | $271 |
| Meloxicam | 23 | $91 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Irwin
- William DecarboBelle Vernon$3.5M
- David PedowitzBryn Mawr$1.6M
- Noman SiddiquiScranton$1.3M
- Peter MangonePittsburgh$1.1M
- Stephen BrigidoBethlehem$656K
- Guido LaportaDunmore$625K
- Adam TeichmanAllentown$545K
- Thomas RocchioAllentown$524K
- Jason MillerMalvern$501K
- James SferraCranberry Township$451K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.